BACKGROUND:  Considering the progressing tendency of administration of nanomaterials products in the world and their entrance to aquatic ecosystems, their toxicity assessment on the aquatic environment and proposing the biocompatible solutions in their production seems indispensable. OBJECTIVES: In this study, the toxicity of silver nanoparticles (AgNPs), chemical and biosynthetic forms were evaluated using the biomarker, artemia nauplii (Artemia fransiscana). METHODS: For toxicity assessment, the OECD standard method was used. The artemia nauplii were exposed to additive serial concentration of biosynthetic and chemical silver nanoparticles. For biosynthesis of silver nanoparticles, aqueous extracts of two species of marine macroalgae Ulva flexuosa (green algae) and Sargassum boveanum (brown algae) were used. Artemia nauplii mortality in the times of 12, 24, 36 and 48 hours after exposure to silver nanoparticles were recorded and analyzed via Probit software. RESULTS: Survey findings showed that not only the toxicity of these three types of silver nanoparticles on artemia nauplii increased in a dose- dependent manner, but also their toxicity increased along with duration of exposure time. The toxicity of these nanoparticles were significantly different (P<0.05). The 48 h LC50 value of chemical AgNPs in the artemia nauplii was 31.8 mg/l, while 48 h LC50 for biosynthesis AgNPs  produced by U. flexuosa, and S. boveanum were 366.96 and 141.16 mg/l respectively. CONCLUSIONS: Comparison of the toxicity of these three types of AgNPs on artemia nauplii showed that, the chemical form of AgNPs was more toxic (up to 10 times) than a biosynthetic form of AgNPs. Moreover, the source of biosynthesis of silver nanoparticles had a considerable impact on toxicity of final production, because a biosynthetic form of AgNPs produced by U. flexuosa was less toxic than the same form prepared from S. boveanum.

BACKGROUND: Application of green chemistry to the synthesis of nanomaterials is of vital importance in medicinal and technological aspects. Recently, synthesis of silver nanoparticles using plants and marine macro algae to adapt this approach to the environment, has become  more popular. Objectives: The purpose of this study is biological synthesis of silver nanoparticles using seaweed, Sargassum angustifolium, and determining its toxicity in common carp. Methods: First, synthesis of silver nanoparticles using Sargassum algae was conducted and then acute toxicity of these silver nanoparticles was investigated at static renewal condition during 96 hours in common carp according to standard methods (1998) OECD. Results: TEM analysis showed that the average size of the bionanoparticles was found to be 32.54 nm and spherical in shape. The toxicity results showed that the LC50 at 24, 48, 72 and 96-h after exposure was 79.54 ± 0.007, 52.17 ± 0.006, 30.62 ± 0.008 and 11.34 ± 0.016 mg/l respectively. Conclusions: Analysis related to the characterization of the properties of silver nanoparticles proves bioreduction of silver ions by sargassum seaweed extract. According to the results the mortality rates of common carp showed an increasing trend with increasing concentration and exposure time, which indicates the toxicity of this substance in high concentration for common carp.

BACKGROUND: Oxidative stress is believed to be one of the major causes of tissue damage in aquatic animals exposed to heavy metals. It leads to certain changes in the antioxidant and enzyme system. Given the fact that research on the effect of sub-acute toxicity of silver nitrate in shrimps is not very developed, the present study can be conducive to formulating the international standards of contamination of shrimps with silver nitrate.OBJECTIVES: The present study aimed to evaluate the toxic effects of silver nitrate on the changes in the antioxidant and enzyme systems of hepatopancreas, muscle and gills of Litopenaeus vannamei.METHODS: After acclimatization of shrimps, they were exposed to silver nitrate with concentrations of 0.0084, 0.021, 0.042 and 0.063 mg/L for 21 days. At the end of the experimental period, gill, muscle and hepatopancreas were sampled, and the changes in the antioxidant system (SOD, GPx and GST) and metabolic enzymes (ALT, ALP, AST and LDH) were examined.RESULTS: There was no significant difference in terms of SOD and GST activity in the gill and muscle of the exposed shrimps (P>0.05). However, GPx in treatment 4 increased significantly in gill and muscle while it saw a decrease in hepatopancreas (P<0.05). In hepatopancreas, GST significantly increased in treatments 3 and 4 (P<0.05) whereas SOD did not show any significant changes compared with other treatments (P>0.05). The metabolic enzymes of the muscle did not show any significant differences in any of the treatments (P>0.05), but in gill, the level of ALT in treatment 4 decreased significantly while the levels of AST and LDH in treatment 3 and 4 significantly increased (P<0.05). In hepatopancreas, the activity of ALT in treatments 2 and 4, AST in treatments 3 and 4, and ALP in all treatment except treatment 1 saw significant reduction. Nevertheless, LDH in treatments 3 and 4 had a significant rise (P<0.05).CONCLUSIONS: A significant increase in GST and LDH as well as a significant decrease in GPx and ALT, AST and ALP enzymes in the hepatopancreas revealed that the antioxidant and enzyme system of shrimps is further disturbed with the rise in silver nitrate concentration in the hepatopancreas compared to the gill and muscle.

Growth of Pasteurella haemolytica A1 in RPMI 1640 medium containing 0.5% bovine serum albumin (BSA) for 2.5 hours enhanced culture supernatant leukotoxic activity [30,700 +/- 12,900 toxic units/ml, compared with leukotoxic activity of culture supernatants produced in RPMI 1640 medium alone (120 +/- 40 toxic units/ml)]. Gel filtration chromatography of the leukotoxic activity from RPMI 1640 medium supernatants in buffer containing 50 mM NaCl indicated a single leukotoxic activity peak (peak I) eluting near the gel resin molecular mass exclusion limit (estimated molecular mass of approx 8,000 kd). In contrast, culture supernatants produced in RPMI 1640 plus bovine serum albumin medium (RPMI + BSA) had peak I and 2 additional leukotoxic activity peaks (peaks II and III) with estimated molecular mass of approximately 80 and < 30 kd, respectively. All leukotoxic activity peaks were composed of approximately 100-kd molecular mass leukotoxin protomer, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting with a monoclonal antibody against leukotoxin. Subjecting culture supernatant leukotoxic activity produced in RPMI + BSA to gel filtration chromatography in buffer containing 500 mM NaCl or 6M urea resulted in detection of only a single leukotoxic activity peak with estimated approximate molecular mass of 250 and 800 kd, respectively. These findings suggest that P haemolytica exists as a high molecular mass aggregate with low leukotoxic activity which, in the presence of BSA, partially disaggregates to multiple toxin forms with enhanced leukotoxic activity. Some of these leukotoxin forms interact with dextran-based gel resins at low ionic strength.

Doxorubicin was encapsulated in canine erythrocytes, treated with 0.32% glutaraldehyde, and administered at a dosage equivalent to 30 mg of free doxorubicin/m(2) of body surface area to dogs with diagnosis of lymphosarcoma. Compared with administration of free doxorubicin, this method of drug delivery substantially reduced peak plasma concentration and prolonged higher plasma concentration of doxorubicin. As such, this method was comparable to continuous IV infusion. Previous studies have indicated this method's potential for reduction in toxic side effects, particularly cardiotoxicosis, while allowing higher total doses of doxorubicin to be administered. In this study, doxorubicin encapsulated in glutaraldehyde-treated erythrocytes induced a triphasic exponential decay of doxorubicin from plasma, the highest relative contribution to the total area of the curve being the terminal phase. The treatment was effective in inducing complete and partial remissions of lymphosarcoma, with minimal acute toxicosis and no evidence of cardiotoxicosis. However, substantial, unanticipated, chronic, nonregenerative myelosuppression developed, and was most strikingly expressed as profound thrombocytopenia. Efforts to ameliorate or circumvent this toxic effect will be required prior to further consideration of this doxorubicin delivery system for treatment of systemic neoplasia.

The cytotoxic effect of Moraxella bovis 118F on bovine neutrophils was evaluated and characterized by use of a 51Cr release assay. Neutrophils harvested from healthy adult cattle were labeled with 51Cr. The leukocidic activity produced by M bovis 118F, a hemolytic strain of M bovis, was heat-labile. A live culture of strain 118F, at a ratio of 100 bacteria/neutrophil, released 97.7% of the 51Cr from labeled neutrophils. Neither a heat-killed preparation of M bovis 118F nor a live or heat-killed preparation of M bovis IBH63 (a nonhemolytic and nonpathogenic strain) induced significant (P > 0.05) release of 51Cr. Moraxella bovis 118F broth culture filtrates prepared for evaluation of leukocidic activity also were evaluated for hemolytic activity. These 2 toxic activities had several characteristics in common. Both were filterable, heat-labile, produced by a hemolytic strain, and were released during early logarithmic phase growth from broth cultures. Leukocidic and hemolytic activities were protected from degradation by phenylmethyl sulfonyl fluoride, a serine protease inhibitor. Leukocidic and hemolytic activities were dependent on calcium ions. Filtrate resulted in 54.1% 51Cr release from labeled neutrophils and contained 646.7 hemolytic U/ml, respectively, when saline (0.85% NaCl) + 10 mM CaCl2 solution was used as diluent. Neither saline solution nor saline + 10 mM MgCl2 solution supported leukocidic or hemolytic activity. Serum, obtained from several calves 10 to 38 days after M bovis inoculation, substantially neutralized leukocidic and hemolytic activities, compared with paired preinoculation serum samples. In addition, no significant difference (P > 0.05) was detected when the ability of each calf's postinfection serum to neutralize leukocidic activity was compared with the ability of the serum to neutralize hemolytic activity.

Effects of dietary ochratoxin A (OA) and T-2 toxin, fed singly and in combination, were evaluated in growing crossbred pigs. Thirty-six barrows (3 replicates of 3 for each of 4 treatment groups, mean body weight, 18.0 kg) were fed: 0 mg of OA and 0 mg of T-2/kg of feed (control); 2.5 mg of OA/kg of feed; 8.0 mg of T-2/kg of feed; or 2.5 mg of OA plus 8.0 mg of T-2/kg of feed for 30 days. Production performance, serum biochemical, hematologic, immunologic, and pathologic evaluations were made. Body weight and body weight gain were decreased by all toxin treatments, but the combination toxin treatment reduced weight gain more than did either of the toxins administered singly and could be considered additive. Liver weight was decreased by combination treatment, whereas kidney weight was increased by OA treatment. Ochratoxin decreased serum cholesterol, inorganic phosphorus, and alkaline phosphatase values; reduced mean cell volume, hemoglobin concentration, and macrophage phagocytosis; and increased creatinine and total protein values. Consumption of T-2 toxin reduced hemoglobin and serum alkaline phosphatase values. The combination treatment decreased serum cholesterol, gamma-glutamyltransferase, alkaline phosphatase, mean cell volume, hematocrit, and hemoglobin values, as well as lymphoblastogenesis and phagocytosis, and increased serum nine concentration. We concluded that OA and T-2, singly or in combination, can affect clinical performance, serum biochemical, hematologic, and immunologic values, and organ weights of growing barrows. Although some analytes were affected more by the combination than by either toxin alone, the interactions could best be described as additive, not synergistic.

In these studies, the effects of recombinant human interleukin 2 (rHuIL-2) were examined on in vitro tumor cytotoxicity by canine blood lymphocytes obtained from peripheral vessels through use of a chromium release microcytotoxicity assay. Cytotoxic activity by lymphokine-activated killer cells was significantly increased, compared with that by untreated lymphocytes in a dose-dependent manner. The maximal effect was attained with 300,000 IU of rHuIL-2/ml. Lymphokine-activated killing also was dependent on the duration of incubation with rHuIL-2. After 1 day of rHuIL-2 incubation, cytotoxicity was significantly increased, compared with that of untreated lymphocytes. Of the 3 times examined, cytotoxicity peaked after 3 days of rHuIL-2 incubation. High levels of cytotoxic activity were still present at 7 days of incubation. Numbers of granular lymphocytes increased over the times examined. These results demonstrate functional and morphologic changes in canine peripheral blood lymphocytes obtained from peripheral vessels after incubation with rHuIL-2 in a dose- and time-dependent manner.